String Of Deaths In Korea Among Inoculated Elderly Not Caused By Vaccines Produced By GSK, Novartis
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Officials at the Korea Centers for Disease Control and Prevention say that the recent deaths of five elderly citizens who had been inoculated with seasonal flu vaccines were not caused by bulk vaccine products supplied by GSK and Novartis
You may also be interested in...
Korea FDA Evaluating H1N1 Vaccine Applications from GSK and Three Korean Pharmas
SEOUL - Korea FDA said it is evaluating three applications for the A/H1N1 flu vaccine submitted by GlaxoSmithKline and Korean companies Green Cross, Boryung Pharmaceutical and Hanwha Pharma
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).